PubMed

Thiazolidinediones upregulate fatty acid uptake and oxidation in adipose tissue of diabetic patients.

Boden G, Homko C, Mozzoli M, Showe LC, Nichols C, Cheung P.

Diabetes. 2005 Mar;54(3):880-5.PMID: 15734868 [PubMed - indexed for MEDLINE]Related articlesFree article

Thiazolidinediones upregulate impaired fatty acid uptake in skeletal muscle of type 2 diabetic subjects.

Wilmsen HM, Ciaraldi TP, Carter L, Reehman N, Mudaliar SR, Henry RR.

Am J Physiol Endocrinol Metab. 2003 Aug;285(2):E354-62. Epub 2003 Apr 15.PMID: 12700163 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of thiazolidinediones on glucose and fatty acid metabolism in patients with type 2 diabetes.

Boden G, Cheung P, Mozzoli M, Fried SK.

Metabolism. 2003 Jun;52(6):753-9.PMID: 12800103 [PubMed - indexed for MEDLINE]Related articles

Insulin resistance and its treatment by thiazolidinediones.

Lebovitz HE, Banerji MA.

Recent Prog Horm Res. 2001;56:265-94. Review.PMID: 11237217 [PubMed - indexed for MEDLINE]Related articlesFree article

Impaired fatty acid metabolism in type 2 diabetic skeletal muscle cells is reversed by PPARgamma agonists.

Cha BS, Ciaraldi TP, Park KS, Carter L, Mudaliar SR, Henry RR.

Am J Physiol Endocrinol Metab. 2005 Jul;289(1):E151-9. Epub 2005 Feb 22.PMID: 15727952 [PubMed - indexed for MEDLINE]Related articlesFree article

Thiazolidinediones enhance insulin-mediated suppression of fatty acid flux in type 2 diabetes mellitus.

Racette SB, Davis AO, McGill JB, Klein S.

Metabolism. 2002 Feb;51(2):169-74.PMID: 11833043 [PubMed - indexed for MEDLINE]Related articles

Regulation of glucose transport and insulin signaling by troglitazone or metformin in adipose tissue of type 2 diabetic subjects.

Ciaraldi TP, Kong AP, Chu NV, Kim DD, Baxi S, Loviscach M, Plodkowski R, Reitz R, Caulfield M, Mudaliar S, Henry RR.

Diabetes. 2002 Jan;51(1):30-6.PMID: 11756319 [PubMed - indexed for MEDLINE]Related articlesFree article

Divergent effects of rosiglitazone on protein-mediated fatty acid uptake in adipose and in muscle tissues of Zucker rats.

Coort SL, Coumans WA, Bonen A, van der Vusse GJ, Glatz JF, Luiken JJ.

J Lipid Res. 2005 Jun;46(6):1295-302. Epub 2005 Mar 16.PMID: 15772429 [PubMed - indexed for MEDLINE]Related articlesFree article

Mechanisms of early insulin-sensitizing effects of thiazolidinediones in type 2 diabetes.

Tonelli J, Li W, Kishore P, Pajvani UB, Kwon E, Weaver C, Scherer PE, Hawkins M.

Diabetes. 2004 Jun;53(6):1621-9. Erratum in: Diabetes. 2005 Feb;54(2):587. PMID: 15161771 [PubMed - indexed for MEDLINE]Related articlesFree article

Thiazolidinediones can rapidly activate AMP-activated protein kinase in mammalian tissues.

LeBrasseur NK, Kelly M, Tsao TS, Farmer SR, Saha AK, Ruderman NB, Tomas E.

Am J Physiol Endocrinol Metab. 2006 Jul;291(1):E175-81. Epub 2006 Feb 7.PMID: 16464908 [PubMed - indexed for MEDLINE]Related articlesFree article

Insulin-sensitizing effects of thiazolidinediones are not linked to adiponectin receptor expression in human fat or muscle.

Li W, Tonelli J, Kishore P, Owen R, Goodman E, Scherer PE, Hawkins M.

Am J Physiol Endocrinol Metab. 2007 May;292(5):E1301-7. Epub 2007 Jan 9. Erratum in: Am J Physiol Endocrinol Metab. 2009 Feb;296(2):E402. PMID: 17213476 [PubMed - indexed for MEDLINE]Related articlesFree article

Tissue-specific actions of antidiabetic thiazolidinediones on the reduced fatty acid oxidation in skeletal muscle and liver of Zucker diabetic fatty rats.

Ide T, Nakazawa T, Mochizuki T, Murakami K.

Metabolism. 2000 Apr;49(4):521-5.PMID: 10778879 [PubMed - indexed for MEDLINE]Related articles

Increased malonyl-CoA levels in muscle from obese and type 2 diabetic subjects lead to decreased fatty acid oxidation and increased lipogenesis; thiazolidinedione treatment reverses these defects.

Bandyopadhyay GK, Yu JG, Ofrecio J, Olefsky JM.

Diabetes. 2006 Aug;55(8):2277-85.PMID: 16873691 [PubMed - indexed for MEDLINE]Related articlesFree article

Changes in adiponectin receptor expression in muscle and adipose tissue of type 2 diabetic patients during rosiglitazone therapy.

Tan GD, Debard C, Funahashi T, Humphreys SM, Matsuzawa Y, Frayn KN, Karpe F, Vidal H.

Diabetologia. 2005 Aug;48(8):1585-9. Epub 2005 Jul 1.PMID: 15991021 [PubMed - indexed for MEDLINE]Related articles

Activation of AMP-activated protein kinase, inhibition of pyruvate dehydrogenase activity, and redistribution of substrate partitioning mediate the acute insulin-sensitizing effects of troglitazone in skeletal muscle cells.

Fediuc S, Pimenta AS, Gaidhu MP, Ceddia RB.

J Cell Physiol. 2008 May;215(2):392-400.PMID: 17960559 [PubMed - indexed for MEDLINE]Related articles

Adiponectin and its response to thiazolidinediones are associated with insulin-mediated glucose metabolism in type 2 diabetic patients and their first-degree relatives.

Hulstrøm V, Højlund K, Vinten J, Beck-Nielsen H, Levin K.

Diabetes Obes Metab. 2008 Nov;10(11):1019-28. Epub 2008 Feb 18.PMID: 18284435 [PubMed - indexed for MEDLINE]Related articles

The effects of rosiglitazone on fatty acid and triglyceride metabolism in type 2 diabetes.

Tan GD, Fielding BA, Currie JM, Humphreys SM, Désage M, Frayn KN, Laville M, Vidal H, Karpe F.

Diabetologia. 2005 Jan;48(1):83-95. Epub 2004 Dec 24.PMID: 15619071 [PubMed - indexed for MEDLINE]Related articles

Role of PPAR- gamma agonist thiazolidinediones in treatment of pre-diabetic and diabetic individuals: a cardiovascular perspective.

Dumasia R, Eagle KA, Kline-Rogers E, May N, Cho L, Mukherjee D.

Curr Drug Targets Cardiovasc Haematol Disord. 2005 Oct;5(5):377-86. Review.PMID: 16248830 [PubMed - indexed for MEDLINE]Related articles

Depot-specific regulation of perilipin by rosiglitazone in a diabetic animal model.

Kim HJ, Jung TW, Kang ES, Kim DJ, Ahn CW, Lee KW, Lee HC, Cha BS.

Metabolism. 2007 May;56(5):676-85.PMID: 17445544 [PubMed - indexed for MEDLINE]Related articles

Effects of metformin and rosiglitazone treatment on insulin signaling and glucose uptake in patients with newly diagnosed type 2 diabetes: a randomized controlled study.

Karlsson HK, Hällsten K, Björnholm M, Tsuchida H, Chibalin AV, Virtanen KA, Heinonen OJ, Lönnqvist F, Nuutila P, Zierath JR.

Diabetes. 2005 May;54(5):1459-67.PMID: 15855334 [PubMed - indexed for MEDLINE]Related articlesFree article